The all-cause mortality of Spiriva Handihaler was also compared to tiotropium inhalation spray 5 mcg (Spiriva Respimat 5 mcg) in an additional long-term, randomized, double-blind, double-dummy ...

In addition, Spiriva Respimat was compared with Spiriva Handihaler in a long-term active-controlled trial in COPD (Trial 6). COPD – 5 Confirmatory Trials The trials included a total of 6614 COPD ...

There are many types of asthma inhalers. They differ in whether they're used for quick relief or long-term control, what type ...

The main US patent expires next year, and in the meantime BI is looking to move patients over to its newer Spiriva and Spiolto Respimat formulations to plug the gap. Anticoagulant Pradaxa’s ...

Boehringer’s lung drug Spiriva, approved for chronic obstructive pulmonary disease (COPD) and asthma, generated net sales of 2.4 billion euros, down 11.4% compared with last year, which the ...

Purpose. The literature was reviewed to determine whether data support current treatment guideline recommendations regarding the use of systemic corticosteroids in the treatment of chronic ...

With the earlier definition of chronic obstructive pulmonary disease (COPD), patients were essentially defined as having either chronic bronchitis or emphysema, with emphysema classified as a ...

It is also important to match the inhaler selection to patients’ ability and preference, including the use of innovative inhalers such as the Respimat ® and Respimat ® re-usable, to help ...